MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,923,738 | +47.6% | 181,904 | +22.5% | 1.54% | +72.4% |
| Q2 2023 | $5,367,220 | +12.4% | 148,553 | +15.7% | 0.90% | -2.5% |
| Q1 2023 | $4,774,135 | +57.6% | 128,406 | +92.1% | 0.92% | +56.7% |
| Q4 2022 | $3,028,792 | -27.1% | 66,846 | +12.3% | 0.59% | -28.4% |
| Q3 2022 | $4,157,000 | -9.7% | 59,516 | -13.3% | 0.82% | -11.7% |
| Q2 2022 | $4,606,000 | -6.4% | 68,613 | +14.7% | 0.93% | +6.3% |
| Q1 2022 | $4,920,000 | -55.8% | 59,837 | -21.1% | 0.87% | -47.8% |
| Q4 2021 | $11,125,000 | +2366.7% | 75,837 | +2872.8% | 1.67% | +4305.3% |
| Q3 2021 | $451,000 | +14.8% | 2,551 | +4.9% | 0.04% | +18.8% |
| Q2 2021 | $393,000 | -97.1% | 2,431 | -96.9% | 0.03% | -96.9% |
| Q1 2021 | $13,547,000 | -16.2% | 79,081 | +7.4% | 1.03% | -9.9% |
| Q4 2020 | $16,174,000 | +13.0% | 73,638 | -41.2% | 1.14% | -13.2% |
| Q2 2020 | $14,310,000 | +151.2% | 125,336 | +69.1% | 1.31% | +20.2% |
| Q1 2020 | $5,696,000 | – | 74,100 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |